No more catheter, no more cuff for monitoring patient vital signs? Sotera Wireless announced the FDA has given 510(k) clearance to its continuous non-invasive blood pressure (cNIBP) technology, a new feature of its ViSi Mobile patient monitoring system. “For the first time clinicians can continuously monitor all patient vital signs, including beat-to-beat blood pressure, without the […]
Antiviral therapies pharmaceutical company Chimerix has raised $45 million that it will apply toward further clinical development of two compounds, one of which could be used as a defense against biological attacks. The Durham, North Carolina-based company is developing another compound for infections associated with HIV.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Gemin X Pharmaceuticals has closed an $8 million Series E round of funding that it will use to prepare for Phase 3 clinical trials of its lung cancer drug. The Malvern, Pennsylvania-based company is in the midst of a Phase 2b trial of its lead candidate, obatoclax, which is intended for the treatment of extensive-stage […]
The company is in the midst of a Phase 2 trial on an ovarian drug that works with women who have developed resistance to chemotherapy. Data from the study will be available as early as mid-2010.